L’hypophyse et ses traitements : comment peuvent-ils influer sur le comportement ?: The pituitary and its treatments: how can they influence behaviour?

Ann Endocrinol (Paris). 2017 Oct:78 Suppl 1:S41-S49. doi: 10.1016/S0003-4266(17)30924-1.
[Article in French]

Abstract

Behaviour may be influenced by pituitary hormones or treatments. Dopamine agonist (DA) indicated in prolactinomas treatment can cause side effects, and especially impulse control disorders. In the context of prolactinomas treatment, impulse control disorders (ICD) have been reported like gambling, compulsive shopping, but mostly hypersexuality. These ICD can occur with low AD doses, and seem to be independent of type of molecule and psychiatric medical history. The main pathophysiologic hypothesis is a dysregulation of dopaminergic pathway involved in reward system. Given the possible devastating social impact of these ICD, they have to be screened in patients treated with DA. Our social behaviour can also be impacted by oxytocin. This hormone secreted on physiologic state at posterior pituitary, but also by others areas of brain and brainstem, has an impact on attachment in pair partners and in parent-child relationship, but also in empathy behaviour. Oxytocin affects as well eating behaviour with an anorexigenic impact. Studies on small populations assessed the relevance of an oxytocin treatment in several endocrine and nutritional pathologies like post-surgery craniopharyngioma, panhypopituitarism and obesity. Despite promising results, several pitfalls prevent yet the oxytocin use in clinical practice.

Keywords: Agonistes dopaminergiques; Attachement social; Comportement alimentaire; Dopamine agonists; Eating behaviour; Impulse control disorders; Ocytocine; Oxytocin; Social attachment; Troubles compulsifs.

Publication types

  • Review

MeSH terms

  • Adult
  • Behavior / drug effects*
  • Child
  • Compulsive Behavior / chemically induced
  • Compulsive Behavior / physiopathology
  • Dopamine Agonists / adverse effects
  • Dopamine Agonists / pharmacology*
  • Empathy / drug effects
  • Humans
  • Interpersonal Relations
  • Oxytocin / adverse effects
  • Oxytocin / pharmacology
  • Parent-Child Relations
  • Pituitary Diseases / physiopathology
  • Pituitary Diseases / psychology
  • Pituitary Diseases / therapy*
  • Pituitary Gland / physiology*
  • Pituitary Hormones / adverse effects
  • Pituitary Hormones / pharmacology*

Substances

  • Dopamine Agonists
  • Pituitary Hormones
  • Oxytocin